Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
NCT ID: NCT02934906
Last Updated: 2016-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
55497 participants
OBSERVATIONAL
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy
NCT02391272
Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia
NCT03492515
IVIg Plus Low Dose rhTPO for ITP in Pregnancy
NCT05634824
The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy
NCT05333744
Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment
NCT01864512
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Pregnant women with anti-HPA antibody negative from the same hospital, the same race, and the same gravidity and parity, who are admitted at the same time.
Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
Observational study.
Experimental Group
pregnant women with anti-HPA antibody positive
Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
Observational study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
Observational study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between Jan 1, 2017 and Dec 31, 2018
Exclusion Criteria
* Plan to terminate pregnancy early
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Air Force Military Medical University, China
OTHER
Shengjing Hospital
OTHER
Qilu Hospital of Shandong University
OTHER
Second Xiangya Hospital of Central South University
OTHER
LanZhou University
OTHER
The First Affiliated Hospital of Bengbu Medical University
OTHER
The Affiliated Hospital Of Guizhou Medical University
OTHER
Sir Run Run Shaw Hospital
OTHER
Jilin University
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
People's Hospital of Xinjiang Uygur Autonomous Region
OTHER
Second Affiliated Hospital of Nanchang University
OTHER
Guangzhou First People's Hospital
OTHER
The Affiliated Hospital Of Southwest Medical University
OTHER
Beijing Chao Yang Hospital
OTHER
Qingdao University
OTHER
Peking University First Hospital
OTHER
RenJi Hospital
OTHER
First Affiliated Hospital of Harbin Medical University
OTHER
MCH Hospital of Yinchuan City
UNKNOWN
Henan Provincial People's Hospital
OTHER
Third Affiliated Hospital, Sun Yat-Sen University
OTHER
The First Affiliated Hospital of Guangdong Pharmaceutical University
OTHER
Xinqiao Hospital of Chongqing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhongjun Li
Professor, Chief of Blood Transfusion Department
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Chen L, Liu Z, Liu T, Ma X, Rao M, Wang Y, Sun B, Yin W, Zhang J, Yan B, Li X, Wang Q, Zhang L, Wen J, Liu F, Wang P, Wei Y, Huang Y, Wu J, Guo Y, Kang Y, Song X, Liu X, Zhang G, Xie T, Chen Y, Zeng X, Li Z. Neonatal alloimmune thrombocytopenia caused by anti-HPA antibodies in pregnant Chinese women: a study protocol for a multicentre, prospective cohort trial. BMC Pregnancy Childbirth. 2017 Aug 31;17(1):281. doi: 10.1186/s12884-017-1453-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V2.0(20160720)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.